Compliance Rate
Compliance Rate
50.0%
Compliant submissions
3
Incompliant submissions
3
Total trials
6
My Organizations' Clinical Trials
Showing 250 of 1457 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/09/24
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 01/26/18
Due: 01/26/19
Phase: N/A
Priority: Normal
Start: 08/22/23
End: 07/31/30
Due: 07/31/31
Phase: N/A
Priority: Normal
Start: 12/07/21
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 08/01/19
End: 11/30/22
Due: 11/30/23
Phase: N/A
Priority: Normal
Start: 12/15/20
End: 07/01/23
Due: 07/01/24
Phase: N/A
Priority: Normal
Start: 09/25/17
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 11/30/99
End: 12/31/02
Due: 12/31/03
Phase: N/A
Priority: Normal
Start: 12/01/12
End: 07/20/15
Due: 07/20/16
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 01/08/18
End: 08/13/18
Due: 08/13/19
Phase: N/A
Priority: Normal
Start: 12/30/21
End: 06/19/23
Due: 06/19/24
Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections
Phase: N/A
Priority: Normal
Start: 08/24/21
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 05/31/08
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 03/22/21
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 01/29/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 01/13/22
Due: 01/13/23
Phase: N/A
Priority: Normal
Start: 11/30/94
End: 12/31/99
Due: 12/31/00
Phase: N/A
Priority: Normal
Start: 12/04/23
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 08/17/17
Due: 08/17/18
Phase: N/A
Priority: Normal
Start: 09/01/24
End: 12/15/25
Due: 12/15/26
Phase: N/A
Priority: Normal
Start: 01/30/17
End: 05/05/18
Due: 05/05/19
Phase: N/A
Priority: Normal
Start: 11/01/24
End: 03/01/29
Due: 03/01/30